Stryker stock heads into the open after a 3.6% slide

At the close on September 15, 2026, Stryker stock finished at USD 282.06 on the NYSE, down 3.6% on the day. Compared with its 52-week high near USD 392.55, the move left the shares more than 28% below that peak as analysts kept a Moderate Buy consensus.

Stryker stock closed at USD 282.06 on the NYSE on September 15, 2026, losing 3.6% from the prior close in a weak broader market session. The shares ended the day well below their 52-week high around USD 392.55, leaving them more than 28% under that peak as investors weighed recent valuation and ratings commentary.

September 15, 2026 in numbers

Stryker Corp. (ISIN US8636671013, NYSE: SYK) finished the last completed session on September 15, 2026 at USD 282.06, compared with a previous close of USD 292.80, a decline of 3.6% on the day. In the same session the stock traded in an intraday range between roughly USD 277 and USD 286, keeping the close near the middle of the day’s band and comfortably within the published 52-week range of USD 267.00 to USD 392.55 reported in recent performance data. Per NYSE data, the move left Stryker more than 28% below its 52-week high, underscoring the pullback from levels seen earlier in 2026. Against that backdrop, the company’s valuation metrics such as a price-earnings ratio near the high-20s were highlighted in recent coverage as investors reassessed how much premium to pay for its growth profile.

While the price weakness was notable, coverage on September 15, 2026 pointed out that Wall Street remains broadly constructive on the shares. As MarketBeat reported on September 15, 2026, twenty-four research firms covering Stryker maintain a Moderate Buy consensus, with eighteen buy ratings and six holds and an average 12-month price target of USD 380.40, well above the latest close. In that same report, the outlet highlighted that the company’s most recent quarterly results topped expectations, with adjusted earnings of USD 3.69 per share on revenue of USD 6.59 billion, up 9.4 percent year over year, and management guiding for fiscal 2026 earnings of USD 14.95 to USD 15.10 per share. The combination of a lower share price and intact growth guidance helped frame the stock’s slide in the latest session more as valuation compression than a reaction to a specific new company setback.

Dividend and analyst signals today

Looking ahead to today and the coming sessions, dividend and rating signals remain relevant for Stryker. According to the analyst consensus summary published by MarketBeat on September 15, 2026, the company recently declared a quarterly dividend of USD 0.88 per share, with shareholders of record on September 30, 2026 set to receive payment on October 30, 2026, implying an annualized yield around 1.2 percent at recent prices. The same report reiterated that institutional investors hold a sizeable majority stake in the company, and that insiders have realized gains through share sales over the past 90 days, adding another data point for market participants assessing supply and demand in the stock. With the shares now trading markedly below the average analyst target and the dividend timeline approaching, these factors could shape sentiment toward Stryker stock as the US market heads into today’s opening bell.